n-tert-butyl-(2-sulfophenyl)nitrone and Huntington-Disease

n-tert-butyl-(2-sulfophenyl)nitrone has been researched along with Huntington-Disease* in 1 studies

Other Studies

1 other study(ies) available for n-tert-butyl-(2-sulfophenyl)nitrone and Huntington-Disease

ArticleYear
Lipoic acid improves survival in transgenic mouse models of Huntington's disease.
    Neuroreport, 2001, Oct-29, Volume: 12, Issue:15

    There is substantial evidence implicating excitotoxicity and oxidative damage in the pathogenesis of Huntington's disease (HD). We therefore examined whether the antioxidants 2-sulpho-tert-phenyibutyinitrone (S-PBN) and alpha-lipoic acid could exert neuroprotective effects in transgenic mouse models of HD. S-PBN showed no effects on either weight loss or survival in the R6/2 transgenic HD mice. alpha-Lipoic acid produced significant increases in survival in both R6/2 and N171-82Q transgenic mouse models of HD. These findings suggest that alpha-lipoic acid might have beneficial effects in HD patients.

    Topics: Animals; Antioxidants; Benzenesulfonates; Body Weight; Brain; Disease Models, Animal; Food, Formulated; Huntington Disease; Male; Mice; Mice, Transgenic; Neuroprotective Agents; Oxidative Stress; Survival; Thioctic Acid; Treatment Outcome

2001